In this report, we presented the finding of a novel pathogenic variant in PUF60 gene in a Chinese child. To our knowledge, this is the first case of a Chinese child with PUF60 mutation. The proband’s clinical presentations of intellectual disability, short stature, and dysmorphic facial features were similar with those previously reported cases with mutations in PUF60 variants or with a deletion of 8q24.3 containing the PUF60 or VRJS [1, 2, 4,5,6,7,8,9]. However, the vertebral anomaly, coloboma, renal defects, and cardiac defects reported in other cases were not found in our patient. In individuals with 8q24.3 deletion or VRJS, both PUF60 and SCRIB genes are deleted. In an early study in zebrafish, morpholino-mediated knockdown of either PUF60 or Scribble (Scrib) in zebrafish recapitulates some of the phenotypes of 8q24.3 deletion in humans [2]. Knockdown of either gene cause a short stature, microcephaly, and reduced jaw size. Knockdown of Scrib alone resulted in coloboma and renal abnormalities, whereas knockdown of PUF60 alone resulted in cardiac structural defects. Knockdown of both genes result in more severe short stature phenotype. It was concluded that PUF60 or SCRIB haploinsufficiency drives the majority of syndromic phenotypes found in patients with the copy number deletion of 8q24.3 or VRJS. However, several patients harboring PUF60 point mutations have been recently described, and these individuals have clinical phenotypes that overlap significantly with patients carrying 8q24.3 deletions. These findings support a major role for PUF60 in the phenotype of VRJS in human [1, 2, 4,5,6,7,8,9]. It remains to be seen whether mutations in SCRIB alone in humans may also cause the clinical problem similar to mutations of PUF60. The presentation of chronic diarrhea in our patient has not been previously reported [1, 2, 4,5,6,7,8,9]. It will be interesting to see if diarrhea is a feature of other patients harboring a PUF60 defect.
The findings of a heterozygous de novo nonsense change of PUF60 in our study further supports haploinsufficiency as the underlying mechanism [6]. Loss-of-function variants are predicted to result in altered dosages of different PUF60 isoforms and, consequently, abnormal splicing of targeted genes [2]. Both VRSJ syndrome and PUF60-related disorder encompass diverse phenotypes, suggesting that dysregulated targeted genes due to the PUF60 deficiency may account for diverse phenotypes in humans.
Interesting to note, two reports have suggested the overlapping clinical features between PUF60 related disorder with CHARGE syndrome. In these cases, the clinical and genetic evaluation of CHARGE syndrome is considered but the mutation study of CHD7 is negative (PMID 29300383 and PMID: 28471317). Other have also suggested the overlapping feature between Cornelia de Lange syndrome and other craniofacial disorders caused by mutations in genes encoding the spliceosomal proteins [11, 12]. The apparent question for the future investigation is whether there is a convergent molecular mechanism among these disorders.
The majority of genetic variants in PUF60 are predicted to be loss of function mutations, However, missense variants are also reported. Clinically, there is no significant difference between individuals carrying clear loss of function and missense variants. These may support the loss of function mechanism underlying the missense variants in these cases. However, additional phenotypical and molecular studies are warranted to clarify the genotype and phenotype correlation and whether the missense variants may result in loss of function at protein level.
This study is the first report of a Chinese Han patient carrying de novo PUF60 heterozygous mutation. The proband exhibited many of the characteristics previously reported in PUF60 variant or VRSJ patients such as intellectual disability, growth retardation, and dysmorphic facial features [1, 2, 4,5,6,7,8,9]. However, the patient did not present with especially vertebral skeletal abnormalities, coloboma, renal defects, or cardiac defects. Clinical and molecular characterization of patients with diverse background will help us better understand the genetic diversity and prevalence of PUF60 related disorder.